|
|
Volumn 30, Issue 3, 1997, Pages 400-403
|
|
Sympatholysis after neuron-specific, N-type, voltage-sensitive calcium channel blockade: First demonstration of N-channel function in humans
a
a
NONE
(United States)
|
|
Author keywords
Calcium channel blocker; SNX 111
|
|
Indexed keywords
CALCIUM CHANNEL BLOCKING AGENT;
OMEGA CONOTOXIN MVIIA;
ADRENERGIC ACTIVITY;
ADULT;
ARTICLE;
CALCIUM ANTAGONISM;
CALCIUM TRANSPORT;
CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
HUMAN;
HUMAN CELL;
HUMAN EXPERIMENT;
HUMAN TISSUE;
INCIDENCE;
INTRACELLULAR TRANSPORT;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
NOCICEPTION;
NORMAL HUMAN;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
VOLTAGE CLAMP;
ADOLESCENT;
ADULT;
BLOOD PRESSURE;
CALCIUM CHANNEL BLOCKERS;
HEART RATE;
HUMANS;
HYPOTENSION, ORTHOSTATIC;
INJECTIONS, INTRAVENOUS;
MALE;
OMEGA-CONOTOXINS;
PEPTIDES;
|
|
EID: 0031441105
PISSN: 01602446
EISSN: None
Source Type: Journal
DOI: 10.1097/00005344-199709000-00019 Document Type: Article |
|
Times cited : (71)
|
|
References (17)
|
